Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
Impact in
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
Papers in
-
- Schizophrenia research and treatment 140
- Bipolar Disorder and Treatment 63
- Attention Deficit Hyperactivity Disorder 30
- Pharmacology 68
- Treatment of Major Depression 63
- Top scholars
- Robert D. McQuadeFrank S. CzerwiecJohn F. OuyangWilliam H. CarsonVicente E. TorresArlene B. ChapmanRonald N. MarcusRonald D. Perrone
- Journals
- Current Medical Research and Opinion (29 papers)Journal of Medical Economics (17 papers)Journal of Affective Disorders (16 papers)Schizophrenia Research (15 papers)Journal of Clinical Psychopharmacology (15 papers)
- Partner nations
- United StatesSpainDenmark
In The Last Decade
Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
459 papers receiving 14.3k citations
Peers
Comparison fields: 5 of 166
- Psychiatry and Mental health 5.4k
- Biological Psychiatry 334
- Pharmacology 2.2k
- Nephrology 883
- Genetics 3.2k
Countries citing scholars working at Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
This map shows the geographic impact of research produced by authors working at Otsuka Pharmaceutical Development & Commercialization, Inc. (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Otsuka Pharmaceutical Development & Commercialization, Inc. (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Otsuka Pharmaceutical Development & Commercialization, Inc. (United States) more than expected).
Fields of papers published by authors at Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
This network shows the impact of papers affiliated with Otsuka Pharmaceutical Development & Commercialization, Inc. (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Otsuka Pharmaceutical Development & Commercialization, Inc. (United States) at the time of their publication.
About Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)
In recent decades, authors affiliated with Otsuka Pharmaceutical Development & Commercialization, Inc. (United States) have published 574 papers, which have received a total of 17.4k indexed citations . Scholars at this organization have produced 222 papers in Psychiatry and Mental health, 68 papers in Pharmacology, 27 papers in Nephrology, 5 papers in Family Practice and 12 papers in Applied Psychology on the topics of Schizophrenia research and treatment (140 papers), Genetic and Kidney Cyst Diseases (68 papers), Bipolar Disorder and Treatment (63 papers), Treatment of Major Depression (63 papers), Attention Deficit Hyperactivity Disorder (30 papers), Tuberculosis Research and Epidemiology (25 papers), Electrolyte and hormonal disorders (22 papers) and Renal Diseases and Glomerulopathies (19 papers). Their work is cited by papers focused on Psychiatry and Mental health (5.4k citations), Biological Psychiatry (334 citations), Pharmacology (2.2k citations), Nephrology (883 citations) and Genetics (3.2k citations). Authors at Otsuka Pharmaceutical Development & Commercialization, Inc. (United States) collaborate with scholars in United States, Spain and Denmark and have published in prestigious journals including Current Medical Research and Opinion, Journal of Medical Economics, Journal of Affective Disorders, Schizophrenia Research and Journal of Clinical Psychopharmacology. Some of Otsuka Pharmaceutical Development & Commercialization, Inc. (United States)'s most productive authors include Robert D. McQuade, Frank S. Czerwiec, John F. Ouyang, William H. Carson, Vicente E. Torres, Arlene B. Chapman, Ronald N. Marcus, Ronald D. Perrone, Holly B. Krasa and Ron T. Gansevoort.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.